Institution of a Subset of the Claims Challenged in an IPR Does Not Thwart Congress’ Efficiency Goal

Jan 26, 2017

Reading Time : 1 min

The DOJ argued, inter alia, that the PTAB’s decision to institute review on some, but not all, of the claims thwarts Congress’ intent that the IPR process be an “efficient system for challenging patents that should not have issued.” The DOJ relied heavily on statements from the legislative history of the America Invests Act (AIA), including views from senators who stated that, in order to meet the efficiency goal, IPR proceedings “should generally serve as a complete substitute for at least some phase of the litigation.” Because the DOJ would be required to litigate both in district court (for at least Claim 13) and before the PTAB, it argued that Congress’ goals were not met.

The PTAB disagreed and stated that it had discretion to institute on fewer than all grounds “for reasons of administrative expediency to ensure timely completion of the instituted proceeding.” The PTAB also cited Federal Circuit precedent, stating that the regulations were an exercise of the PTO’s rulemaking authority and that its interpretation of the statute was reasonable. In sum, the PTAB held that it had not “overlooked or misapprehended Congress’ goal of creating an ‘efficient system for challenging patents that should not have issued.’”

Share This Insight

Previous Entries

IP Newsflash

July 22, 2026

The Court of Federal Claims recently denied the United States’ motion to dismiss a patent infringement suit related to production of a COVID-19 vaccine. The court held that it had jurisdiction because the plaintiff filed its claim there before it filed a parallel suit in a district court and because it adequately pleaded the government’s involvement.

...

Read More

IP Newsflash

July 13, 2026

In a precedential and sua sponte Director Review decision, USPTO Director Squires recently vacated three related institution decisions nearly six months after institution where a district court later found the challenged claims invalid. Because the fourteen-day deadline to request Director Review of the institution decisions had passed, the Director used this opportunity to formally extend the deadline in two ways. First, he extended the fourteen-day deadline under 37 C.F.R. § 42.75(c)(1) to thirty days, which “puts requests for Director Review of decisions to institute trial on equal footing to requests for Director Review of final decisions or decisions not to institute trial.” Second, he outlined certain “exceptional circumstances” that warrant a further extension of the deadline to account for changes in the case that “surface after the deadline.” In the case at hand, the Director found the district court’s invalidity finding to be such an “exceptional circumstance” and ultimately initiated review and vacated the institution decisions on that basis.

...

Read More

IP Newsflash

June 5, 2026

The Supreme Court unanimously held that for a complaint of induced infringement, a patent owner must allege that the accused infringer took affirmative, not passive, steps to encourage direct infringement. Thus, where a generic drug has a skinny label, to induce infringement of the carved-out patented use of the drug, the generic company must have taken steps that were designed to cause others to perform the patented use, not just steps that could cause such conduct.

...

Read More

IP Newsflash

May 07, 2026

The Northern District of Illinois granted a summary judgment motion of no invalidity based on indefiniteness because the qualitative terms like “sufficiently slow” and “desired period of time” were definite when viewed in light of the surrounding claim language and specification.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.